Home » Authors » Douglas Merrill

Articles by Douglas Merrill

Wilex Expands uPA Program Through Deal With San Raffaele

Feb. 19, 2003

By Douglas Merrill

Biotech Companies Included In New German Stock Index

Feb. 19, 2003

By Douglas Merrill

Biotech Companies Included In New German Stock Index

Feb. 19, 2003

By Douglas Merrill

Wilex Expands uPA Program Through Deal With San Raffaele

Feb. 19, 2003

By Douglas Merrill

Ingenium Adds GSF Mouse Data To Ingenotyping Modeling Platform

Feb. 12, 2003

By Douglas Merrill

Boehringer Ingelheim Starts Phase III Trial Of HIV Inhibitor

Feb. 12, 2003

By Douglas Merrill

Ingenium Adds GSF Mouse Data To Ingenotyping Modeling Platform

Feb. 12, 2003

By Douglas Merrill

Boehringer Ingelheim Starts Phase III Trial Of HIV Inhibitor

Feb. 12, 2003

By Douglas Merrill

European VCs See Tough Exits, Put Emphasis On Product Firms

Feb. 5, 2003

By Douglas Merrill

European VCs See Tough Exits, Put Emphasis On Product Firms

Feb. 5, 2003

By Douglas Merrill

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....